Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: Reversal by L-arginine

American Journal of Physiology - Renal Physiology

Volumn 272, Issue 2 41-2, 1997, Pages

  Wolzt, Michael ^a,c   Schmetterer, Leopold ^a   Ferber, Wolfgang ^a   Artner, Erika ^b   Mensik, Christa ^a   Eichler, Hans Georg ^a   Krejcy, Kurt ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Humans; Nitric oxide physiology

Indexed keywords

ARGININE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ENZYME INHIBITION; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY PLASMA FLOW; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030875764     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1997.272.2.f178     Document Type: Article

References (32)

1. Arnal, J. F., L. Warin, and J. B. Michel. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J. Clin. Invest. 90: 647-652, 1992.
2. Bachmann, S., and P. Mundel. Nitric oxide in the kidney: synthesis, localisation, and function. Am. J. Kidney Dis. 24: 112-129, 1994.
3. Baudouin, S. V., P. Bath, J. F. Martin, R. Du Bois, and T. W. Evans. L-Arginine infusion has no effect on systemic haemodynamics in normal volunteers, or systemic and pulmonary haemodynamics in patients with elevated pulmonary vascular resistance. Br. J. Clin. Pharmacol. 36: 45-49, 1993.
4. Bauer, J. A., J. A. Wald, S. Doran, and D. Soda. Endogenous nitric oxied in expired air: effects of acute exercise in humans. Life Sci. 55: 1903-1909, 1994.
5. Bijlsma, J. A., A. J. Rabelink, K. A. H. Kaasjager, and H. A. Koomans. L-Arginine does not prevent the renal effects of endothelin in humans. J. Am. Soc. Nephrol. 5: 1508-1516, 1995.
6. Clarkson, P. B., P. O. Lim, and T. M. MacDonald. Influence of basal nitric oxide secretion on cardiac function in man. Br. J. Clin. Pharmacol. 40: 299-305, 1995.
7. Granger, J. P., A. M. Alberola, F. J. Salazar, and T. Nakamura. Control of renal hemodynamics during intrarenal and systemic blockade of nitric oxide synthesis in conscious dogs. J. Cardiovasc. Pharmacol. 20, Suppl. 12: S160-S162, 1992.
8. Haynes, W. G., J. P. Noon, B. R. Walker, and D. J. Webb. Inhibition of nitric oxide synthesis increases blood pressure in healthy subjects. J. Hypertens. 11: 1375-1380, 1993.
9. Hibbs, J. B., C. Westenfelder, R. Taintor, Z. Vavrin, C. Kablitz, R. L. Baranowski, J. H. Ward, R. L. Menlove, M. P. McMurry, and J. P. Kushner. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. 89: 867-877, 1992.
10. Higashi, Y., T. Oshima, R. Ozono, M. Watanabe, H. Matsuura, and G. Kajiyama. Effects of L-arginine infusion on renal hemodynamics in patients with mild essential hypertension. Hypertension Dallas 25: 898-902, 1995.
11. Hishikawa, K., T. Nakaki, M. Tsuda, H. Esumi, H. Ohshima, H. Suzuki, T. Saruta, and R. Kato. Effect of L-arginine administration on hemodynamics and nitric oxide release in man. Jpn. Heart J. 33: 41-48, 1992.
12. Huang, P. L., Z. Huang, H. Mashimo, K. D. Bloch, M. A. Moskowitz, J. A. Bevan, and M. C. Fishman. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature Lond. 377: 239-242, 1995.
13. Jakob, G., J. Mair, K. P. Vorderwinkler, G. Judmaier, P. König, H. Zwierzina, M. Pichler, and B. Puschendorf. Clinical significance of urinary cyclic guanosine monophosphate in diagnosis of heart failure. Clin. Chem. 40: 96-100, 1994.
14. Jilma, B., J. Kastner, C. Mensik, B. Vondrovec, J. Hildebrandt, K. Krejcy, O. F. Wagner, and H. G. Eichler. Sex differences in concentrations of exhaled nitric oxide and plasma nitrate. Life Sci. 58: 469-476, 1996.
15. Kharitonov, S. A., D. Yates, R. A. Robbins, R. Logan-Sinclair, E. A. Shinebourne, and P. J. Barnes. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343: 133-135, 1994.
16. Krejcy, K., L. Schmetterer, J. Kastner, M. Nieszpaur-Los, B. Monitzer, W. Schütz, H. G. Eichler, and P. A. Kyrie. Role of nitric oxide in hemostatic system activation in humans. Arterioscler. Thromb. Vasc. Biol. 15: 2063-2067, 1995.
17. G-nitro-L-arginine methyle ester on renal function and blood pressure. Am. J. Physiol. 261 (Renal Fluid Electrolyte Physiol. 30): F1033-F1037, 1991.
18. MacAllister, R., and P. Vallance. Nitric oxide in essential and renal hypertension. J. Am. Soc. Nephrol. 5: 1057-1065, 1994.
19. Mimran, A., J. Ribstein, and G. DuCailar. Contrasting effect of antihypertensive treatment on the renal response to L-arginine. Hypertension Dallas 26: 937-941, 1995.
20. Raij, L., and C. Baylis. Glomerular actions of nitric oxide. Kidney Int. 48: 20-32, 1995.
21. Roth, E., R. Steininger, S. Winkler, F. Längle, T. Grünberger, and R. Függer. L-Arginine deficiency after liver transplantation as an effect of arginase efflux from the graft. Influence on nitric oxide metabolism. Transplantation 57: 665-669, 1994.
22. Stamler, J. S., E. Loh, M. A, Roddy, K. E. Currie, and M. A. Creager. Nitric oxide regulates basal systemic and pulmonary vascular in healthy humans. Circulation 89: 2035-2040, 1994.
23. Stolley, P. D., and B. L. Strom. Sample size calculation for clinical pharmacology studies. Clin. Pharmacol. Ther. 39: 489-490, 1986.
24. Thorup, C., and A. E. G. Persson. Macula densa derived nitric oxide in regulation of glomerular capillary pressure. Kidney Int. 49: 430-436, 1996.
25. Vallance, P., A. Leone, A. Calver, J. Collier, and S. Moncada. Accumulation of an endogenous inhibitor of nitric oxide synthesis in renal failure. Lancet 339: 572-575, 1992.
26. Vallance, P., S. Patton, K. Bhagat, R. MacAllister, M. Radomski, S. Moncada, and T. Malinski. Direct measurement of nitric oxide in human beings. Lancet 346: 153-154, 1995.
27. Vorderwinkler, K. P., E. Artner-Dworzak, G. Jakob, J. Mair, F. Dienstl, M. Pichler, and B. Puschendorf. Release of cyclic guanosine monophosphate evaluated as a diagnostic tool in cardiac diseases. Clin. Chem. 37: 186-190, 1991.
28. G-hydroxy-L-arginine prevents the haemodynamic effects of nitric oxide synthesis inhibition in the anaesthesized rat. Br. J. Pharmacol. 107: 476-480, 1992.
29. Wennmalm, A., G. Benthin, A. Edlund, L. Jungersten, N. Kieler-Jensen, S. Lundin, U. N. Westfelt, A. S. Petersson, and F. Waagstein. Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ. Res. 73: 1121-1127, 1993.
30. Winlaw, D. S., G. A. Smythe, A. M. Keogh, C. G. Schyvens, P. M. Spratt, and P. S Macdonald. Increased nitric oxide production in heart failure. Lancet 344: 373-374, 1994.
31. Wough, W. H., and P. T. Beall. Simplified measurement of para-aminohippurate and of other arylamines in plasma and urine. Kidney Int. 5: 429-436, 1974.
32. Zeballos, G. A., R. D. Bernstein, C. I. Thompson, P. R. Forfia, N. Seyedi, W. Shen, P. M. Kaminski, M. S. Wolin, and T. H. Hintze. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation 91: 2982-2988, 1995.